genetics versus behavior in cancer development
Published 2 weeks ago • 19 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
3:58
cancer genetics 101: insurance for ngs & closing points-patient education ambassadors 2023-24
-
4:16
cancer genetics 101: standard vs liquid biopsy - program: patient education ambassadors 2023-24
-
8:59
cancer genetics 101: ngs companies and reading ngs reports - patient education ambassadors 2023-24
-
2:50
cancer genetics 101: next generation sequencing - program: patient education ambassadors 2023-24
-
4:36
cancer genetics 101: genetic mutations in cancer - program: patient education ambassadors 2023-24
-
2:01
should we use dna or rna for ngs? - 2022 program: targeted therapies forum
-
1:59:57
grace - global resource for advancing cancer education live stream
-
1:59
rna or dna: which ngs test to use - 2022 program: targeted therapies forum
-
1:21
why are non-mutated egfr genes called "wild type?"
-
6:05
what are ntrk mutations? - 2022 program: targeted therapies forum
-
4:11
risk factors for head and neck cancers - testing and early diagnosis
-
5:56
biopsies in lung cancer: tumor vs. liquid - lcvl 2024
-
4:52
onctalk 2021 - neoadjuvant therapy vs. adjuvant therapy: what is the current role?
-
2:09
high pd-l1:wait for genetic testing results before treatment?-targeted therapies in lung cancer 2023
-
2:22:00
onctalk 2022 -- on demand full video
-
6:56
2020 ttf rare mutations qa panel why mutations have different progression-free survival averages
-
3:06
prevalence of targeted driver mutations in nsclc - 2022 program: targeted therapies forum - english
-
1:36
braf and ntrk inhibitors: their role in early nsclc - 2022 program: targeted therapies forum
-
6:42
maintenance systemic therapy: the nrg-lu trial - onctalk lung 2023